Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: A phase I trial (GASTO-1021)-Reference-Cited by-同舟云学术

Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: A phase I trial (GASTO-1021)

Published:2021-02 Issue: Volume:155 Page:105-112
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Chen Nai-Bin,Li Qi-Wen,Li Su,Guo Su-Ping,Wu Ying-Jia,Cheng Zhangkai J,Li Ji-Bin,Wang Da-Quan,Liu Fang-Jie,Ai Xin-Lei,Hu Nan,Qiu Bo,Liu Hui

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Epidemiology of esophageal cancer in Japan and China;Lin;J Epidemiol,2013

3. Esophageal cancer: risk factors, genetic association, and treatment;Huang;Asian J Surg,2018

4. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01);Cooper;Radiat Ther Oncol Group Jama,1999

5. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus;Ajani;J Natl Cancer Inst,1994

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059);Cancer Medicine;2023-06-16

2. Moderately hypo-fractionated radiotherapy combined with S-1 in inoperable locally advanced esophageal squamous cell carcinoma: A prospective, single-arm phase II study (GASTO-1045);Frontiers in Oncology;2023-03-10

3. Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies;Frontiers in Oncology;2022-10-07

4. TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis;BioMed Research International;2022-05-10

5. Genotoxicity of nedaplatin in cultured lymphocytes: modulation by vitamin E;Drug and Chemical Toxicology;2021-12-29